ArticleNature communications2026
Rapid evolution of Klebsiella pneumoniae biofilms in vitro delineates adaptive changes selected during infection.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Targeting KPC-ProducingMicroorganisms · 2026Article
- Intestinal mucus acts as a nutrient source and signal forMicrobiome research reports · 2026Article
- Molecular response to the non-lytic peptide bac7 (1-35) triggers disruption of Klebsiella pneumoniae biofilm.PLoS pathogens · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biofilm formation facilitates infection by the opportunistic pathogen Klebsiella pneumoniae, primarily via indwelling medical devices. Here, we explore the adaptive evolution of classical pathotype K. pneumoniae in surface-attached biofilms through experimental evolution that mimics catheter-associated infections. We observe rapid convergent evolution that alters or abolishes capsule production, modifies the fimbrial adhesin MrkD, or increases the production of fimbriae and cellulose via upregulated c-di-GMP-dependent pathways. We show that multiple aspects of biofilm formation, including early attachment, topology, surface preference, and extracellular matrix composition, are affected in a mutation-specific manner. However, evolutionary trajectories and resulting phenotypes show strain-specific differences, illustrating the importance of genetic background on biofilm adaptation. Additionally, changes in acute virulence are linked to the underlying genetic change rather than the overall biofilm capacity. Identified adaptive changes conferring hypermucoviscosity or affecting c-di-GMP-related regulatory pathways overlap extensively with those previously identified in clinical UTI and wound isolates, confirming biofilm as an important selective trait in vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.